AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Hourly Market Review - Nov 18, 2024 9 AM
Generated by AI AgentAinvest Market Brief
Monday, Nov 18, 2024 10:00 am ET1min read
Movers of the hour:
Aclaris Therapeutics is up 36.58% at $2.80.
Fate Therapeutics is up 34.12% at $2.71.
Super Micro Computer is up 19.08% at $22.13.
Regenxbio is up 16.30% at $11.20.
Destiny Tech100 is up 16.16% at $37.39.
Here are the top stocks upgraded by Wall Street analyst:
Apple has received a rating of Strong Buy from Needham with target price increased to $260 from $260.
Apple has received a rating of Strong Buy from Rosenblatt with target price increased to $262 from $261.
Apple has received a rating of Sell from Barclays with target price dropped to $184 from $186.
Apple has received a rating of Neutral from Maxim Group with target price increased to $215 from $203.
Nvidia has received a rating of Buy from Oppenheimer with target price increased to $175 from $150.
Nvidia has received a rating of Strong Buy from HSBC with target price increased to $200 from $145.
Nvidia has received a rating of Strong Buy from Susquehanna with target price increased to $180 from $160.
Nvidia has received a rating of Strong Buy from Raymond James with target price increased to $170 from $140.
Nvidia has received a rating of Buy from Wedbush with target price increased to $160 from $138.
Ainvest Market Brief
Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.
Latest Articles
Morning Market Pulse: Trump Trade War Threats and Fed Uncertainty Weigh on Markets
Dec.23 2025
What to Trade Today: Gold and Copper Rally as Biotech and Metals Stocks Offer Volatile Short-Term Gaps
Dec.23 2025
U.S. Corporate Actions | Ticker Changes and Dividend Announcements Highlight Activity
Dec.23 2025
Morning Market Pulse: Trump Housing Overhaul & AI Surge Drive Pre-Market Moves
Dec.22 2025
Morning Market Pulse: Trump’s Federal Pay Raise & Japan’s Policy Shift Drive Pre-Market Moves
Dec.19 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet